Comprehensive Guidelines for the
Development of Drugs and Biological
Products to Combat COVID-19: Industry Insights
Comprehensive Guidelines for the Development of Drugs and Biological Products to Combat COVID-19: Industry Insights The FDA's recommendations concentrate on phases 2 and 3 trials, encompassing critical elements such as trial population, design, efficacy endpoints, safety considerations, and statistical aspects. In
